Advisor Group’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Advisor Group’s Portfolio BSPM Stock Details BSPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-39	Closed	–	–	5119
2017 Q2	$0	Buy	+39	New	+$68	﹤0.01%	5077

Other funds holding BSPM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group's BSPM Position: Q3 2017 in Review

Advisor Group sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2017, closing a stake of 39 shares.

Advisor Group first reported a position in BSPM in Q2 2017 and held it in 1 quarter. The position peaked at $0 in Q2 2017. 5 funds tracked by Wall St. Rank hold BSPM as of Q3 2017.

Advisor Group reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Advisor Group sold 39 Biostar Pharmaceuticals, Inc. shares in Q3 2017.
Advisor Group first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2017 and held it in 1 quarter.
Advisor Group's Biostar Pharmaceuticals, Inc. position peaked at $0 in Q2 2017.
5 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2017.

Based on Advisor Group's 13F filing for Q3 2017, filed 6 Nov 2017.